HLB Starts Rivoceranib Site Planning to Diversify Supply Chain 김진수 2025.04.01 오후 04:51 Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse] 김새미 2025.03.11 오전 08:10 계열사 50곳...M&A로 덩치불린 HLB의 목적지는 임정요 2025.02.25 오전 08:06 HLB, CRL 2번 수령해도 中 항서제약 품을 수밖에 없는 이유 김새미 2025.03.26 오전 09:05 HLB Group Stocks Plunge After FDA Rejects Liver Cancer Drug Approval Again[K-Bio Pulse] 김진수 2025.03.24 오전 08:00 HLB Rebounds After CRL, Eyes FDA Decision by July[K-Bio Pulse] 나은경 2025.03.25 오전 07:49 HLB’s NDA Rejected Again; Resubmission in May, FDA Decision by July 김새미 2025.03.23 오후 05:16 Anigen·Daehwa·HLB. Strong Momentum[K-BIO Pulse] 김지완 2025.03.18 오전 08:18 HLB’s Liver Cancer Drug Expected to Gain Approval in Europe: When Will EMA Approval Come? 김진수 2025.02.28 오전 07:56 Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse] 김새미 2025.03.21 오전 08:00 더 보기 로딩중..
rivoceranib
rivoceranib
![Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031100284b.jpg)
![HLB Group Stocks Plunge After FDA Rejects Liver Cancer Drug Approval Again[K-Bio Pulse]](https://image.edaily.co.kr/images/photo/files/NP/S/2025/03/PS25032400143b.jpg)
![HLB Rebounds After CRL, Eyes FDA Decision by July[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032500216b.jpg)
![Anigen·Daehwa·HLB. Strong Momentum[K-BIO Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031800287b.jpg)
![Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032100275b.jpg)